Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis | 6 | 2022 | 1170 | 1.910 |
Why?
|
Hepatitis | 3 | 2023 | 227 | 1.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 7 | 2016 | 379 | 1.020 |
Why?
|
Gastritis | 2 | 2022 | 196 | 0.920 |
Why?
|
Enterocolitis | 1 | 2022 | 102 | 0.800 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 370 | 0.790 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 814 | 0.760 |
Why?
|
Methylprednisolone | 1 | 2021 | 387 | 0.720 |
Why?
|
DNA Glycosylases | 3 | 2020 | 128 | 0.690 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 77 | 0.680 |
Why?
|
Colitis, Lymphocytic | 1 | 2019 | 25 | 0.680 |
Why?
|
Alanine Transaminase | 1 | 2021 | 592 | 0.670 |
Why?
|
Pancreatitis | 2 | 2023 | 1092 | 0.650 |
Why?
|
Gastroparesis | 1 | 2020 | 131 | 0.640 |
Why?
|
Melanoma | 3 | 2020 | 5510 | 0.590 |
Why?
|
Education, Medical, Continuing | 1 | 2022 | 840 | 0.590 |
Why?
|
Immunotherapy | 5 | 2022 | 4445 | 0.570 |
Why?
|
Mucous Membrane | 1 | 2019 | 673 | 0.520 |
Why?
|
Adenomatous Polyposis Coli | 3 | 2015 | 224 | 0.500 |
Why?
|
Neoplasms | 7 | 2023 | 21683 | 0.470 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1170 | 0.420 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 319 | 0.400 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 188 | 0.400 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 806 | 0.360 |
Why?
|
Genetic Testing | 5 | 2020 | 3444 | 0.350 |
Why?
|
Gastroenterology | 1 | 2016 | 536 | 0.350 |
Why?
|
Diarrhea | 3 | 2022 | 1348 | 0.340 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10943 | 0.340 |
Why?
|
Paracentesis | 1 | 2009 | 95 | 0.340 |
Why?
|
Colorectal Neoplasms | 5 | 2020 | 6773 | 0.320 |
Why?
|
Dysentery | 1 | 2007 | 15 | 0.310 |
Why?
|
Adenoma | 2 | 2020 | 2174 | 0.290 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.280 |
Why?
|
Vitamin D | 1 | 2020 | 3223 | 0.280 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 345 | 0.270 |
Why?
|
Early Detection of Cancer | 3 | 2016 | 3086 | 0.270 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 643 | 0.270 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5256 | 0.260 |
Why?
|
Intestine, Small | 1 | 2012 | 1241 | 0.260 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2425 | 0.260 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2007 | 264 | 0.260 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 514 | 0.250 |
Why?
|
Medical Oncology | 1 | 2016 | 2265 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2375 | 0.240 |
Why?
|
Peutz-Jeghers Syndrome | 2 | 2016 | 50 | 0.230 |
Why?
|
Radioimmunotherapy | 1 | 2023 | 91 | 0.230 |
Why?
|
Liver | 1 | 2018 | 7474 | 0.210 |
Why?
|
Educational Measurement | 1 | 2009 | 1210 | 0.210 |
Why?
|
Internal Medicine | 1 | 2009 | 1009 | 0.210 |
Why?
|
Glucocorticoids | 2 | 2022 | 2107 | 0.210 |
Why?
|
Retrospective Studies | 9 | 2023 | 77449 | 0.200 |
Why?
|
Lymphadenitis | 1 | 2022 | 98 | 0.200 |
Why?
|
Medical History Taking | 1 | 2004 | 783 | 0.190 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2020 | 88 | 0.180 |
Why?
|
Pancreatitis, Chronic | 2 | 2016 | 285 | 0.180 |
Why?
|
Liver Function Tests | 1 | 2021 | 528 | 0.180 |
Why?
|
Genes, APC | 1 | 2020 | 159 | 0.180 |
Why?
|
Immune System Diseases | 1 | 2022 | 262 | 0.180 |
Why?
|
Humans | 34 | 2023 | 744343 | 0.170 |
Why?
|
Middle Aged | 17 | 2022 | 213383 | 0.170 |
Why?
|
Jews | 1 | 2020 | 385 | 0.160 |
Why?
|
Gastric Emptying | 1 | 2020 | 233 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6364 | 0.160 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1788 | 0.150 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2291 | 0.150 |
Why?
|
Adult | 13 | 2023 | 214055 | 0.140 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 2031 | 0.140 |
Why?
|
Abdominal Pain | 1 | 2022 | 1063 | 0.140 |
Why?
|
Drug Resistance | 1 | 2021 | 1609 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2016 | 3479 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 101 | 0.130 |
Why?
|
Female | 19 | 2021 | 380194 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3923 | 0.120 |
Why?
|
Feces | 1 | 2020 | 1401 | 0.120 |
Why?
|
Clinical Competence | 1 | 2009 | 4687 | 0.120 |
Why?
|
Genetic Counseling | 2 | 2009 | 600 | 0.110 |
Why?
|
Male | 16 | 2021 | 350118 | 0.110 |
Why?
|
Aged | 10 | 2021 | 163280 | 0.110 |
Why?
|
Acute Disease | 1 | 2023 | 7149 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8428 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1855 | 0.110 |
Why?
|
Lymphocytes | 1 | 2020 | 2617 | 0.100 |
Why?
|
Endosonography | 1 | 2016 | 610 | 0.100 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.100 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 63 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1770 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2541 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1253 | 0.090 |
Why?
|
Internship and Residency | 1 | 2009 | 5788 | 0.080 |
Why?
|
Pedigree | 2 | 2009 | 4644 | 0.080 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 7181 | 0.080 |
Why?
|
Phenotype | 3 | 2020 | 16365 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2020 | 2987 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.080 |
Why?
|
Neutrophils | 1 | 2020 | 3719 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1379 | 0.070 |
Why?
|
Intestinal Fistula | 1 | 2007 | 140 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 426 | 0.070 |
Why?
|
Disease Progression | 1 | 2022 | 13284 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 15226 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2291 | 0.070 |
Why?
|
Pyrroles | 1 | 2012 | 1146 | 0.060 |
Why?
|
Colonic Diseases | 1 | 2007 | 202 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 29063 | 0.060 |
Why?
|
Colonoscopy | 2 | 2010 | 1367 | 0.060 |
Why?
|
Logistic Models | 3 | 2010 | 13408 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4186 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1839 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 25043 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9687 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5221 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2488 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4851 | 0.050 |
Why?
|
Mass Screening | 2 | 2010 | 5255 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2728 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4803 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13695 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2007 | 1530 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6365 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 931 | 0.050 |
Why?
|
Pyrimidines | 1 | 2012 | 2942 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2007 | 1035 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 85781 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4215 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13102 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 17446 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 12804 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 63114 | 0.030 |
Why?
|
Triage | 1 | 2020 | 976 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12959 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3588 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15076 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7279 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2004 | 3528 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19905 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12245 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7322 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5720 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 72290 | 0.020 |
Why?
|
Alleles | 1 | 2015 | 6933 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2684 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2616 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
United States | 1 | 2010 | 69872 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_